In response to "In utero exposure to methotrexate and risk of congenital malformations"
- PMID: 25959112
- PMCID: PMC4618601
- DOI: 10.1002/ajmg.a.37151
In response to "In utero exposure to methotrexate and risk of congenital malformations"
Comment on
-
Maternal exposure to methotrexate and birth defects: a population-based study.Am J Med Genet A. 2014 Sep;164A(9):2212-6. doi: 10.1002/ajmg.a.36625. Epub 2014 Jun 4. Am J Med Genet A. 2014. PMID: 24898111 Free PMC article.
-
In utero exposure to methotrexate and risk of congenital malformations.Am J Med Genet A. 2015 Oct;167A(10):2488-9. doi: 10.1002/ajmg.a.37153. Epub 2015 May 5. Am J Med Genet A. 2015. PMID: 25943497 No abstract available.
References
-
- Piggott KD, Sorbello A, Riddle E, DeCampli W. Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure? Pediatr Cardiol. 2011;32(4):518–520. - PubMed
-
- Poggi SH, Ghidini A. Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy. Fertil Steril. 2011;96(3):669–671. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
